Selected research
Industry Research
Teriparatide Injection Industry Research Report 2026
Market perspective
The global Teriparatide Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Teriparatide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Teriparatide Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Teriparatide Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Teriparatide Injection include Shenzhen Salubris Pharmaceuticals Co., Ltd., Shanghai United Cell Biotechnology Co., Ltd., Pfenex Inc., Eli Lilly and Company and Alvogen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Teriparatide Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Teriparatide Injection Market by Company
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Shanghai United Cell Biotechnology Co., Ltd.
Pfenex Inc.
Eli Lilly and Company
Alvogen
Teriparatide Injection Segment by Type
2.5ML
3.0ML
Teriparatide Injection Segment by Application
Hospital
Clinic
Others
Teriparatide Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Teriparatide Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Teriparatide Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Teriparatide Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Teriparatide Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Teriparatide Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Teriparatide Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 2.5ML
- 3.0ML
Applications
- Hospital
- Clinic
- Others
Companies covered
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Shanghai United Cell Biotechnology Co., Ltd.
- Pfenex Inc.
- Eli Lilly and Company
- Alvogen
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Teriparatide Injection Market Size (2021-2032)
- 2.2.2 Global Teriparatide Injection Sales (2021-2032)
- 2.2.3 Global Teriparatide Injection Market Average Price (2021-2032)
- 2.3 Teriparatide Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 2.5ML
- 2.3.3 3.0ML
- 2.4 Teriparatide Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Teriparatide Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Teriparatide Injection Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Teriparatide Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Teriparatide Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Teriparatide Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Teriparatide Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Teriparatide Injection, Product Type & Application
- 3.8 Global Manufacturers of Teriparatide Injection, Established Date
- 3.9 Global Teriparatide Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Shenzhen Salubris Pharmaceuticals Co., Ltd.
- 4.1.1 Shenzhen Salubris Pharmaceuticals Co., Ltd. Company Information
- 4.1.2 Shenzhen Salubris Pharmaceuticals Co., Ltd. Business Overview
- 4.1.3 Shenzhen Salubris Pharmaceuticals Co., Ltd. Teriparatide Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Shenzhen Salubris Pharmaceuticals Co., Ltd. Teriparatide Injection Product Portfolio
- 4.1.5 Shenzhen Salubris Pharmaceuticals Co., Ltd. Recent Developments
- 4.2 Shanghai United Cell Biotechnology Co., Ltd.
- 4.2.1 Shanghai United Cell Biotechnology Co., Ltd. Company Information
- 4.2.2 Shanghai United Cell Biotechnology Co., Ltd. Business Overview
- 4.2.3 Shanghai United Cell Biotechnology Co., Ltd. Teriparatide Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shanghai United Cell Biotechnology Co., Ltd. Teriparatide Injection Product Portfolio
- 4.2.5 Shanghai United Cell Biotechnology Co., Ltd. Recent Developments
- 4.3 Pfenex Inc.
- 4.3.1 Pfenex Inc. Company Information
- 4.3.2 Pfenex Inc. Business Overview
- 4.3.3 Pfenex Inc. Teriparatide Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfenex Inc. Teriparatide Injection Product Portfolio
- 4.3.5 Pfenex Inc. Recent Developments
- 4.4 Eli Lilly and Company
- 4.4.1 Eli Lilly and Company Company Information
- 4.4.2 Eli Lilly and Company Business Overview
- 4.4.3 Eli Lilly and Company Teriparatide Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Eli Lilly and Company Teriparatide Injection Product Portfolio
- 4.4.5 Eli Lilly and Company Recent Developments
- 4.5 Alvogen
- 4.5.1 Alvogen Company Information
- 4.5.2 Alvogen Business Overview
- 4.5.3 Alvogen Teriparatide Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Alvogen Teriparatide Injection Product Portfolio
- 4.5.5 Alvogen Recent Developments
5 Global Teriparatide Injection Market Scenario by Region
- 5.1 Global Teriparatide Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Teriparatide Injection Sales by Region: 2021-2032
- 5.2.1 Global Teriparatide Injection Sales by Region: 2021-2026
- 5.2.2 Global Teriparatide Injection Sales by Region: 2027-2032
- 5.3 Global Teriparatide Injection Revenue by Region: 2021-2032
- 5.3.1 Global Teriparatide Injection Revenue by Region: 2021-2026
- 5.3.2 Global Teriparatide Injection Revenue by Region: 2027-2032
- 5.4 North America Teriparatide Injection Market Facts & Figures by Country
- 5.4.1 North America Teriparatide Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Teriparatide Injection Sales by Country (2021-2032)
- 5.4.3 North America Teriparatide Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Teriparatide Injection Market Facts & Figures by Country
- 5.5.1 Europe Teriparatide Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Teriparatide Injection Sales by Country (2021-2032)
- 5.5.3 Europe Teriparatide Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Teriparatide Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Teriparatide Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Teriparatide Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Teriparatide Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Teriparatide Injection Market Facts & Figures by Country
- 5.7.1 South America Teriparatide Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Teriparatide Injection Sales by Country (2021-2032)
- 5.7.3 South America Teriparatide Injection Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Teriparatide Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Teriparatide Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Teriparatide Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Teriparatide Injection Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Teriparatide Injection Sales by Type (2021-2032)
- 6.1.1 Global Teriparatide Injection Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Teriparatide Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Teriparatide Injection Revenue by Type (2021-2032)
- 6.2.1 Global Teriparatide Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Teriparatide Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Teriparatide Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Teriparatide Injection Sales by Application (2021-2032)
- 7.1.1 Global Teriparatide Injection Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Teriparatide Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Teriparatide Injection Revenue by Application (2021-2032)
- 7.2.1 Global Teriparatide Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Teriparatide Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Teriparatide Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Teriparatide Injection Value Chain Analysis
- 8.1.1 Teriparatide Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Teriparatide Injection Production Mode & Process
- 8.2 Teriparatide Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Teriparatide Injection Distributors
- 8.2.3 Teriparatide Injection Customers
9 Global Teriparatide Injection Analyzing Market Dynamics
- 9.1 Teriparatide Injection Industry Trends
- 9.2 Teriparatide Injection Industry Drivers
- 9.3 Teriparatide Injection Industry Opportunities and Challenges
- 9.4 Teriparatide Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst